Biopure Corporation Receives Notice of Delisting from Nasdaq
18 7월 2009 - 4:30AM
PR Newswire (US)
CAMBRIDGE, Mass., July 17 /PRNewswire-FirstCall/ -- Biopure
Corporation (NASDAQ:BPUR) announced that it has received notice
from The Nasdaq Stock Market, by letter dated July 17, 2009, that
its common stock would be delisted from Nasdaq. The notice stated
that because of concerns raised by the Company's filing for
protection under Chapter 11 of the Bankruptcy Code, trading would
be suspended at the opening of business on July 28, 2009. The
company does not intend to appeal this decision. Biopure
Corporation Biopure Corporation develops and markets
pharmaceuticals, called oxygen therapeutics, that are intravenously
administered to deliver oxygen to the body's tissues. Contact: Zaf
Zafirelis Biopure Corporation (617) 234-6500 DATASOURCE: Biopure
Corporation CONTACT: Zaf Zafirelis of Biopure Corporation,
+1-617-234-6500, Web Site: http://www.biopure.com/
Copyright
Biopure (MM) (NASDAQ:BPUR)
과거 데이터 주식 차트
부터 5월(5) 2024 으로 6월(6) 2024
Biopure (MM) (NASDAQ:BPUR)
과거 데이터 주식 차트
부터 6월(6) 2023 으로 6월(6) 2024
Biopure (MM) (나스닥)의 실시간 뉴스: 최근 기사 0
More Biopure (MM) News Articles